Introduction {#Sec1}
============

Noninvasive ventilation (NIV) has shown benefit in term of decrease in mortality in COPD exacerbation. The nebulized bronchodilators are mostly prescribed as the role of reversible of obstruction in these patients. However, there have been few studies demonstrating the factors those affect the aerosol delivery during NIV.

Objectives {#Sec2}
==========

We aimed to investigate the effect of different positions of exhalation port and nebulizer, ventilator setting delivered by NIV on the amount of aerosol bronchodilator delivery during simulated spontaneous breathing.

Methods {#Sec3}
=======

A noninvasive ventilator (Covidien Puritan Bennett® 560^TM^) was connected to a lung model that simulated spontaneous breathing. The noninvasive ventilator was set for the spontaneous mode, trigger 2 L/min, back up respiratory rate 13/min and target tidal volume of 0.4 L. A nebulizer was filled with 5 mg of albuterol in 3 ml of solution driven with 8 L/min oxygen source. The experimental settings varied in the following features: 1)Bi-level positive-airway-pressure ventilator (BIPAP) settings with the inspiratory positive airway pressure and expiratory positive airway pressure (EPAP) of 10/5, 15/10, 15/5, and 20/10 and continuous positive airway pressure of 5 and 10 cmH~2~O and 2)Two mask types were used: one, in which the leak port was incorporated into the mask(vented mask) and the nebulizer connected directly to mask(Figure [1A](#Fig1){ref-type="fig"}) and another in which the leak port was incorporated into the circuit(non-vented mask)(Figure [1B](#Fig1){ref-type="fig"} and [1C](#Fig1){ref-type="fig"}).In non-vented mask group, the nebulizers were placed either proximal to leak port (Figure [1B](#Fig1){ref-type="fig"}) or distal to leak port (between leak port and lung simulator)(Figure [1C](#Fig1){ref-type="fig"}).Figure 1**Schematic diagram of experimental procedure and different types of mask and bebulizer positions.**

Albuterol was collected with a filter and measured the percent amount delivered by infrared spectrophotometry.

Results {#Sec4}
=======

Albuterol delivery in NIV varied between 6.73 ± 0.44% to 37.01 ± 4.31% of the nominal dose. There were the significant difference in albuterol delivery between the mask types and nebulizer positions under 4 combinations of BIPAP levels and 2 levels of CPAP (p \< 0.001)(Figure [2](#Fig2){ref-type="fig"})Figure 2**Efficiency of albuterol delivery during NIV system at different IPAP and EPAP levels and nebulizers position.**

The highest albuterol delivery was observed with the nebulizer operating at the distal position. The system in which the nebulizer is connected directly to the vented mask had the lowest aerosol delivery (p \< 0.001) (Figure [2](#Fig2){ref-type="fig"}). Under different levels of BIPAP setting, the higher levels of EPAP show significantly decrease in albuterol delivery (21.15 ± 10.58%with EPAP 10 cmH~2~O vs. 23.15 ± 9.73%with EPAP 5 cmH~2~O, p \< 0.001).

Conclusions {#Sec5}
===========

Albuterol delivery with NIV was affected by the position of leak port and nebulizer and the ventilator setting. We recommend placing the nebulizer operating at the distal position to the leak port.
